These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26435503)

  • 1. NFκB-p50 as a blood based protein marker for early diagnosis and prognosis of head and neck squamous cell carcinoma.
    Gupta A; Kumar R; Sahu V; Agnihotri V; Singh AP; Bhasker S; Dey S
    Biochem Biophys Res Commun; 2015 Nov; 467(2):248-53. PubMed ID: 26435503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of p38αMAP kinase: a prognostic marker in HNSCC with respect to radiation therapy.
    Gill K; Mohanti BK; Ashraf MS; Singh AK; Dey S
    Clin Chim Acta; 2012 Jan; 413(1-2):219-25. PubMed ID: 21982916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of p38α in peripheral blood mononuclear cells (PBMC): a potential blood protein marker of head and neck squamous cell carcinoma.
    Gill K; Kumar R; Mohanti BK; Dey S
    Clin Transl Oncol; 2013 Nov; 15(11):969-73. PubMed ID: 23553334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
    Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
    J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of circulating biomarker score in advanced-stage head and neck squamous cell carcinoma.
    Park MJ; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
    Eur J Cancer; 2018 Mar; 92():69-76. PubMed ID: 29428866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDK4 in lung, and head and neck cancers in old age: evaluation as a biomarker.
    Banerjee J; Pradhan R; Gupta A; Kumar R; Sahu V; Upadhyay AD; Chaterjee P; Dwivedi S; Dey S; Dey AB
    Clin Transl Oncol; 2017 May; 19(5):571-578. PubMed ID: 27815686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic value of E-cadherin, MMP-9, activated MMP-13 and anti-p53 antibodies in squamous cell carcinomas of head and neck].
    Al Kassam D; Alvarez Marcos C; Blanco I; de Los Toyos JR; Llorente JL
    Med Clin (Barc); 2007 Dec; 129(20):761-5. PubMed ID: 18093475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-free mitochondrial DNA copy number variation in head and neck squamous cell carcinoma: A study of non-invasive biomarker from Northeast India.
    Kumar M; Srivastava S; Singh SA; Das AK; Das GC; Dhar B; Ghosh SK; Mondal R
    Tumour Biol; 2017 Oct; 39(10):1010428317736643. PubMed ID: 29072129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, Prognosis, and Monitoring of Head and Neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort Study.
    Schröck A; Leisse A; de Vos L; Gevensleben H; Dröge F; Franzen A; Wachendörfer M; Schröck F; Ellinger J; Teschke M; Wilhelm-Buchstab T; Landsberg J; Holdenrieder S; Hartmann G; Field JK; Bootz F; Kristiansen G; Dietrich D
    Clin Chem; 2017 Jul; 63(7):1288-1296. PubMed ID: 28515105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical value of serum HMGB1 in diagnosis and prognosis of laryngeal squamous cell carcinoma.
    Qiu G; Li Y; Liu Z; Wang M; Ge J; Bai X
    Med Oncol; 2014 Dec; 31(12):316. PubMed ID: 25373322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum biomarkers for detection of head and neck squamous cell carcinoma.
    Mydlarz WK; Hennessey PT; Wang H; Carvalho AL; Califano JA
    Head Neck; 2016 Jan; 38(1):9-14. PubMed ID: 24995714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Level of Matrix Metalloproteinase-9 in Patients with Head and Neck Squamous Cell Carcinoma.
    Stanciu AE; Zamfir-Chiru-Anton A; Stanciu MM; Popescu CR; Gheorghe DC
    Clin Lab; 2016 Aug; 62(8):1569-1574. PubMed ID: 28164611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of Tiam1 protein expression in head and neck squamous cell carcinoma: a retrospective study.
    Yang H; Cai YC; Cao Y; Song M; An X; Xia Y; Wei J; Jiang WQ; Shi YX
    Chin J Cancer; 2015 Sep; 34(12):614-21. PubMed ID: 26369827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating miRNA is a novel marker for head and neck squamous cell carcinoma.
    Hsu CM; Lin PM; Wang YM; Chen ZJ; Lin SF; Yang MY
    Tumour Biol; 2012 Dec; 33(6):1933-42. PubMed ID: 22811001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating small non-coding RNA signature in head and neck squamous cell carcinoma.
    Victoria Martinez B; Dhahbi JM; Nunez Lopez YO; Lamperska K; Golusinski P; Luczewski L; Kolenda T; Atamna H; Spindler SR; Golusinski W; Masternak MM
    Oncotarget; 2015 Aug; 6(22):19246-63. PubMed ID: 26057471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
    Duffey DC; Chen Z; Dong G; Ondrey FG; Wolf JS; Brown K; Siebenlist U; Van Waes C
    Cancer Res; 1999 Jul; 59(14):3468-74. PubMed ID: 10416612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Levels of IGF-1 and IGFBP-3 in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell Carcinomas.
    Kalfert D; Ludvikova M; Topolcan O; Celakovsky P; Kucera R; Windrichova J; Ludvik J; Skalova K; Kulda V; Pesta M; Plzak J
    Anticancer Res; 2017 Jun; 37(6):3281-3286. PubMed ID: 28551677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocyte CD40 expression in head and neck squamous cell carcinoma (HNSCC).
    Sathawane D; Kharat RS; Halder S; Roy S; Swami R; Patel R; Saha B
    Hum Immunol; 2013 Jan; 74(1):1-5. PubMed ID: 23000501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of interleukins 4 and 10 in head and neck squamous cell carcinoma.
    Mojtahedi Z; Khademi B; Yehya A; Talebi A; Fattahi MJ; Ghaderi A
    J Laryngol Otol; 2012 Feb; 126(2):175-9. PubMed ID: 21888745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients.
    de Vos L; Gevensleben H; Schröck A; Franzen A; Kristiansen G; Bootz F; Dietrich D
    Clin Epigenetics; 2017; 9():125. PubMed ID: 29213339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.